Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses. Thornburg NJ, Nannemann DP, Blum DL, Belser JA, Tumpey TM, Deshpande S, Fritz GA, Sapparapu G, Krause JC, Lee JH, Ward AB, Lee DE, Li S, Winarski KL, Spiller BW, Meiler J, Crowe JE (2013) J Clin Invest 123: 4405-9 Recognition of MHC TL gene products by gamma delta T cells. Van Kaer L, Wu M, Ichikawa Y, Ito K, Bonneville M, Ostrand-Rosenberg S, Murphy DB, Tonegawa S (1991) Immunol Rev 120: 89-115 Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency. Stanic AK, De Silva AD, Park JJ, Sriram V, Ichikawa S, Hirabyashi Y, Hayakawa K, Van Kaer L, Brutkiewicz RR, Joyce S (2003) Proc Natl Acad Sci U S A 100: 1849-54 Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Ravichandran KS, Igras V, Shoelson SE, Fesik SW, Burakoff SJ (1996) Proc Natl Acad Sci U S A 93: 5275-80 X-ray crystal structure of an anti-Buckminsterfullerene antibody fab fragment: biomolecular recognition of C(60). Braden BC, Goldbaum FA, Chen BX, Kirschner AN, Wilson SR, Erlanger BF (2000) Proc Natl Acad Sci U S A 97: 12193-7 Production and characterization of a monoclonal islet cell surface autoantibody from the BB rat. Brogren CH, Hirsch F, Wood P, Druet P, Poussier P (1986) Diabetologia 29: 330-3 Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action. Thomsen IP, Sapparapu G, James DBA, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE (2017) J Infect Dis 215: 1124-1131 Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics. Smith SA, de Alwis R, Kose N, Durbin AP, Whitehead SS, de Silva AM, Crowe JE (2013) J Infect Dis 207: 1898-908 The natural autoantibody repertoire of nonobese diabetic mice is highly active. Thomas JW, Kendall PL, Mitchell HG (2002) J Immunol 169: 6617-24 The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. Xu H, Yin D, Naziruddin B, Chen L, Stark A, Wei Y, Lei Y, Shen J, Logan JS, Byrne GW, Chong AS (2003) J Immunol 170: 1531-9 The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination. Kovalik JP, Singh N, Mendiratta SK, Martin WD, Ignatowicz L, Van Kaer L (2000) J Immunol 165: 1285-93 Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors. Ding JW, Zhou T, Zeng H, Ma L, Verbeek JS, Yin D, Shen J, Chong AS (2008) J Immunol 180: 261-8 Cutting edge: the ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase C theta and NF-kappa B. Stanic AK, Bezbradica JS, Park JJ, Van Kaer L, Boothby MR, Joyce S (2004) J Immunol 172: 4667-71 The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedure. Madsen OD, Cohen RM, Fitch FW, Rubenstein AH, Steiner DF (1983) Endocrinology 113: 2135-44 Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. Hicar MD, Chen X, Briney B, Hammonds J, Wang JJ, Kalams S, Spearman PW, Crowe JE (2010) J Acquir Immune Defic Syndr 54: 223-35 Antioxidant effects of dihydrocaffeic acid in human EA.hy926 endothelial cells. Huang J, de Paulis T, May JM (2004) J Nutr Biochem 15: 722-9 Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth. Chukwuma VU, Kose N, Sather DN, Sapparapu G, Falk R, King H, Singh V, Lampley R, Malherbe DC, Ditto NT, Sullivan JT, Barnes T, Doranz BJ, Labranche CC, Montefiori DC, Kalams SA, Haigwood NL, Crowe JE (2018) PLoS One 13: e0209437 Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches. Crowe JE (2009) Vaccine 27 Suppl 6: G47-51 Eradication of persistent reovirus infection from a B-cell hybridoma. Dermody TS, Chappell JD, Hofler JG, Kramp W, Tyler KL (1995) Virology 212: 272-6 Peptide dependency of alloreactive CD4+ T cell responses. Mendiratta SK, Kovalik JP, Hong S, Singh N, Martin WD, Van Kaer L (1999) Int Immunol 11: 351-60 Novel islet, duct, and acinar cell markers defined by monoclonal autoantibodies from prediabetic BB rats. Contreas G, Jørgensen J, Madsen OD (1990) Pancreas 5: 540-7 NanoLiterBioReactor: long-term mammalian cell culture at nanofabricated scale. Prokop A, Prokop Z, Schaffer D, Kozlov E, Wikswo J, Cliffel D, Baudenbacher F (2004) Biomed Microdevices 6: 325-39 Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area. Goyarts EC, Vegh Z, Kalergis AM, Hörig H, Papadopoulos NJ, Young AC, Thomson CT, Chang HC, Joyce S, Nathenson SG (1998) Mol Immunol 35: 593-607 Characterization of functional mannose receptor in a continuous hybridoma cell line. Vigerust DJ, Vick S, Shepherd VL (2012) BMC Immunol 13: 51 Production and characterization of mouse ureteric bud cell-specific rat hybridoma antibodies utilizing subtractive immunization and high-throughput screening. Mernaugh RL, Yan H, Chen D, Edl J, Hanley G, Pozzi A, Zent R (2005) J Immunol Methods 306: 115-27 An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. Yu X, McGraw PA, House FS, Crowe JE (2008) J Immunol Methods 336: 142-51
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.